Allied health professions

SnapCare Co-Founder Jeff Richards Named a 2024 Georgia Titan

Retrieved on: 
Wednesday, January 31, 2024
APP, Zoo, Zoo Atlanta, Nursing, Grady Memorial Hospital, MBA, Allied health professions, Software, Workforce, Management

ATLANTA, Jan. 31, 2024 /PRNewswire/ -- SnapCare Chief Development and Operations Officer Jeff Richards has been named a 2024 Georgia Titan 100 in recognition of his outstanding leadership and vision.

Key Points: 
  • ATLANTA, Jan. 31, 2024 /PRNewswire/ -- SnapCare Chief Development and Operations Officer Jeff Richards has been named a 2024 Georgia Titan 100 in recognition of his outstanding leadership and vision.
  • "It's a true honor to be chosen as a Georgia Titan," Richards said.
  • "We proudly recognize the Titan 100 for their efforts to shape the future of the Georgia business community.
  • Sponsored by Wipfli LLP, the 2024 Georgia Titan 100 will be honored at a gala on May 9, 2024, at Zoo Atlanta.

THE AMERICAN ACADEMY OF COSMETIC SURGERY (AACS) MARKS ITS 40th ANNIVERSARY WITH A COMPREHENSIVE SCIENTIFIC MEETING, PRE-MEETING WORKSHOP, AND DIVERSE OFFERINGS

Retrieved on: 
Tuesday, January 16, 2024
BBL, Dermatology, Research, Nutrition, Accreditation, Greatest, Surgeon, AACS, Lecture, ASM, General surgery, Hilton New Orleans Riverside, Practice management, Safety, Otorhinolaryngology, Plastic surgery, DMD, MPH, Breast, Education, Fountain of Youth, Physician, Immediate, American Journal, Elective surgery, Female, Male, Woman, Mortality, CME, Patient, Allied health professions, Rhinoplasty, Tropical medicine, Continuing medical education, Ophthalmology, Disease, DRS, American Academy, Public health, All, Patient safety, Dentistry

CHICAGO, Jan. 16, 2024 /PRNewswire/ -- The American Academy of Cosmetic Surgery (AACS), the world's largest multi-specialty home for physicians dedicated to cosmetic surgery and aesthetic medicine, will present its 40th Annual Scientific Meeting (ASM) on February 22-24, 2024, with an optional pre-meeting workshop on Ultrasound for Safe Brazilian Butt Lift Surgery and More, on Wednesday, February 21.

Key Points: 
  • In celebration of the AACS' 40th Annual Scientific Meeting, and the 40-year anniversary of the formation of the Academy and its official publication, The American Journal of Cosmetic Surgery, the meeting includes a comprehensive scientific program, as well as an array of advocacy, enrichment, networking and 40th anniversary celebratory activities.
  • Offering 41 educational sessions , the 2024 AACS ASM features foremost experts spanning diverse background specialties, such as dermatology, otolaryngology, general surgery, oral, and maxillofacial surgery, ophthalmology, and plastic and reconstructive surgery.
  • J. Kevin Duplechain, MD, FAACS, cosmetic surgeon and Immediate Past-President of the AACS and Cosmetic Surgery Foundation, will deliver the prestigious Webster Lecture on Friday, February 23.
  • Cosmetic surgery practitioners may register here for the 2024 AACS ASM.

Eyenovia Reports Third Quarter 2023 Financial Results and Provides Business Update

Retrieved on: 
Monday, November 13, 2023
CNS, Acquisition, Mydriasis, Audit committee, Telecanthus, Visual acuity, CFO, Headache, Net, Patient, Presbyopia, Research, Element, Tropicamide, Lomb, Growth, Inflammation, Vomiting, Intraocular pressure, ACE, ADT Inc., American Academy, Abnormal psychology, New Drug Application, Nausea, Tachycardia, Mouth, Hypersensitivity, NDA, Allied health professions, International Joint Commission, Photophobia, Psychotic Reaction, Cholinergic, Pilocarpine, Pallor, Reader's Digest, Blood pressure, Bausch, Carbachol, Near-sightedness, Allergy, FDA, Contact, Central nervous system, PDUFA, Hypertonia, Pharmaceutical industry, Management, Nursing, Telescopic sight, Video game, Euronext, Ophthalmology

NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage, topical ophthalmic company leveraging its Optejet® dispensing technology for both internally developed and acquired programs as well as out-licensing for additional indications, today announced its financial and operating results for the third quarter ended September 30, 2023.

Key Points: 
  • Advanced its Gen-2 Optejet device and anticipates shipping to MicroPine partners Bausch and Lomb and Arctic Vision by year-end 2023.
  • Research and development expenses totaled approximately $3.6 million for the third quarter of 2023 as compared to $3.9 million for the third quarter of 2022.
  • For the third quarter of 2023, general and administrative expenses were approximately $2.9 million, compared to $3.4 million for the third quarter of 2022.
  • Total operating expenses for the third quarter of 2023 were approximately $6.5 million compared to $7.2 million for the third quarter of 2022.

Harding University announces Occupational Therapy Graduate Program in its College of Allied Health

Retrieved on: 
Thursday, December 7, 2023
COMT, Research, Doctor of Science, Curriculum, Learning, College, Student, OT, Nature, Professional, Occupational therapy, COVID-19, University, Allied health professions, Outline of health sciences, Employment, Harding University, Physical therapy, Education, Nursing

SEARCY, Ark., Dec. 7, 2023 /PRNewswire/ -- Harding University has announced a new Occupational Therapy (OT) Masters of Science program that can be completed in two years in its College of Allied Health. The program will join other rehabilitative therapeutic practices at Harding, including Cardiac Function & Interventional Technology; Physical Therapy; Physician Assistant Studies; Speech Language Pathology; and Strength & Conditioning.

Key Points: 
  • SEARCY, Ark., Dec. 7, 2023 /PRNewswire/ -- Harding University has announced a new Occupational Therapy (OT) Masters of Science program that can be completed in two years in its College of Allied Health.
  • Harding University has announced a new Occupational Therapy Masters of Science program in its College of Allied Health.
  • "We're proud to unveil this huge undertaking by Harding's staff and College of Allied Health faculty," said Dean for Allied Health and Associate Provost for Health Sciences at Harding Michael McGalliard, ScD, PT, COMT.
  • Curriculum in the Occupational Therapy program will focus on the core of practice as an occupational therapist, occupational therapy process, professionalism and integrity, and global citizenship.

Sierra College Nursing Program Ranked #1 in California by RegisteredNurse.org

Retrieved on: 
Monday, December 4, 2023
Bachelor, Nursing credentials and certifications, College, Student, Allied health professions, BSN, Registered nurse, ADN, Sierra College, School, Associate degree, NCLEX, Nursing, Science

ROCKLIN, Calif., Dec. 4, 2023 /PRNewswire-PRWeb/ -- Sierra College is proud to announce the recognition of the Sierra College Registered Nursing program as the number one program in the "15 Best ADN (Associate Degree in Nursing) Programs in the Western Region for 2024," by RegisteredNurse.org.

Key Points: 
  • Sierra College is proud to announce the recognition of the Sierra College Registered Nursing program as the number one program in the "15 Best ADN (Associate Degree in Nursing) Programs in the Western Region for 2024," by RegisteredNurse.org.
  • ROCKLIN, Calif., Dec. 4, 2023 /PRNewswire-PRWeb/ -- Sierra College is proud to announce the recognition of the Sierra College Registered Nursing program as the number one program in the "15 Best ADN (Associate Degree in Nursing) Programs in the Western Region for 2024," by RegisteredNurse.org.
  • "Nursing students at Sierra College start from the first semester practicing board type questions, making them critically think," said Nancy James, MS, R.N (registered nurses), NP, Dean, Nursing and Allied Health Sciences at Sierra College.
  • "Critical thinking is imperative to effective nursing, and this recognition shows that Sierra College nursing students are ready when they leave our campus to immediately contribute as employable nurses."

UNC Charlotte and Ready to Hire Join Forces to Strengthen North Carolina's Allied Health Workforce

Retrieved on: 
Wednesday, November 15, 2023
School, Healthcare Facilities Accreditation Program, Student, Pharmacy, AMN, Novant Health, University, Allied health professions, Partnership, UNC, Hospital, Pharmacy technician, Nursing, Hire

CHARLOTTE, N.C., Nov. 15, 2023 /PRNewswire/ -- UNC Charlotte School of Professional Studies and Ready to Hire powered by Cengage Group, a workforce solutions provider, today announced a partnership to improve opportunities for North Carolina job seekers and strengthen the talent pool for local healthcare systems in need of skilled allied health professionals.

Key Points: 
  • CHARLOTTE, N.C., Nov. 15, 2023 /PRNewswire/ -- UNC Charlotte School of Professional Studies and Ready to Hire powered by Cengage Group, a workforce solutions provider, today announced a partnership to improve opportunities for North Carolina job seekers and strengthen the talent pool for local healthcare systems in need of skilled allied health professionals.
  • "Through this partnership, UNC Charlotte will provide employer-sponsored train-to-hire programs for in-demand allied health roles at local healthcare systems across the state."
  • According to a survey from AMN Healthcare 85% of healthcare facilities reported Allied Health talent shortages in October 2022.
  • "We are thrilled to partner with Ready to Hire and UNC Charlotte, as this collaboration allows us to tap into our local workforce and create a new pool of entry-level allied health talent," says Michael Paquette, Senior Director, Pharmacy at Novant Health.

Eyenovia to Sponsor Course on Drug Delivery Innovation at IJCAHPO’s 51st Annual Continuing Education (ACE) Program

Retrieved on: 
Monday, October 30, 2023
FDA, Refractive surgery, Optometry, Tropicamide, Joint Commission on Allied Health Personnel in Ophthalmology, Presbyopia, ACE, Inflammation, Phenylephrine, American Academy, International Joint Commission, American Academy of Ophthalmology, American Academy of Optometry, Allied health professions, Somatosensory system, Mydriasis, Pain, Pharmaceutical industry, Ophthalmology

NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic technology company commercializing Mydcombi™ for mydriasis, preparing for regulatory approval of APP130007 for relief of pain and inflammation post ocular surgery, and incorporating its advanced Optejet® device for use both in connection with its own drug-device therapeutic product candidates for presbyopia and pediatric progressive myopia as well as out-licensing for additional indications, today announced that it is sponsoring a course during the International Joint Commission on Allied Health Personnel in Ophthalmology (IJCAHPO) 51st Annual Continuing Education (ACE) program, which is being held November 3-5 in San Francisco.

Key Points: 
  • The course, Topical Pharmaceutical Drug Delivery Innovations: The Potential Role for the New Ophthalmic Spray, will offer ophthalmic technicians background on Eyenovia’s Optejet dispensing technology and training on the use of Mydcombi in daily practice.
  • “We continue to ramp our internal manufacturing capabilities, staff our sales management team and obtain additional key state licenses of which we now have eight either completed or in process.
  • We look forward to transitioning to a broader commercial launch of Mydcombi in early 2024.”
    Topical Pharmaceutical Drug Delivery Innovations: The Potential Role for the New Ophthalmic Spray
    Francis Mah, M.D., Director of Cornea and External Disease and the Co-Director, Refractive Surgery at Scripps Clinic.
  • In addition, Mydcombi was featured in a white paper on Touch Ophthalmology, Pharmacologic Mydriasis and Cycloplegia: A Review of Novel Delivery Devices, which can be accessed here .

HCA Healthcare Announces Grant to University of California, Riverside

Retrieved on: 
Wednesday, November 1, 2023
Hospitals, Philanthropy, Practice Management, Managed Care, Health, Fund Raising, University, Other Philanthropy, Education, Faculty, Armed Forces Post Graduate Medical Institute, Medical school, HCA, FIU, NYSE, Outline of health sciences, Hispanic-serving institution, UCR, History, Physician, UCR School of Business, Psychiatry, TSU, HCA Healthcare, Mentorship, Historically black colleges and universities, FAMU, Hsi Lai Temple, School, University of California, Riverside academics, Student, Partnership, Neurology, University of Texas at Austin, Graduate medical education, Galen College of Nursing, Allied health professions, Florida International University, Fisk University, Emergency medicine, Nursing, UTEP, Medicine

HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that it will gift $620,000 to the University of California, Riverside (UCR) to support five scholarships for students enrolled in the UCR School of Medicine.

Key Points: 
  • HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that it will gift $620,000 to the University of California, Riverside (UCR) to support five scholarships for students enrolled in the UCR School of Medicine.
  • HCA Healthcare has now announced approximately $7.42 million to multiple colleges and universities towards that commitment.
  • HCA Healthcare, through its local facility Riverside Community Hospital, will also provide job shadowing opportunities, mentors for Mission Award recipients and seminar and leadership session opportunities.
  • Nationally, HCA Healthcare is the largest sponsor of Graduate Medical Education in the United States, with 72 teaching hospitals in 16 states.

UCB announces U.S. FDA approval of ZILBRYSQ® (zilucoplan) for the treatment of adults with generalized myasthenia gravis

Retrieved on: 
Tuesday, October 17, 2023
Neonatal Fc receptor, UCB, MuSK protein, Food, MG, University of North Carolina at Chapel Hill, MAC, System, Disease, Immunoglobulin G, Hospital, Plasmapheresis, Oklahoma Office of the Chief Medical Examiner, Brussels Stock Exchange, NMJ, GMG, Diarrhea, Physician, RAISE, U.S. FDA, Neuromuscular junction, University, Safety, Lancet Neurology, Patient, The Lancet, Week, MD, Allied health professions, Myasthenia, Quality of life, Muscle weakness, Acetylcholine receptor, Travel, QMG, Neuromuscular disease, Fatigue, FDA, Upper respiratory tract infection, Pathology, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Priority review, ACHR, Weakness, Pharmaceutical industry, Vaccine, Medicine, Neurology, C5

It is the only once-daily gMG target therapy for self-administration by adult patients with anti-AChR antibody-positive gMG.

Key Points: 
  • It is the only once-daily gMG target therapy for self-administration by adult patients with anti-AChR antibody-positive gMG.
  • Patients were randomized in a 1:1 ratio to receive daily subcutaneous injections of 0.3 mg/kg ZILBRYSQ or placebo for 12 weeks.
  • The most common adverse reactions (≥10%) in patients with gMG were injection site reactions, upper respiratory tract infection, and diarrhea.
  • The primary endpoint for the RAISE study was change from baseline to Week 12 in the Myasthenia Gravis-Activities of Daily Living (MG-ADL) score.

Zydus appoints Mr. Punit Patel as President and CEO to lead its business operations in North America

Retrieved on: 
Monday, October 16, 2023
MCPHS University, Cardinal Health, CVS Health, Allied health professions, Zydus Lifesciences, Therapy, CVS Caremark, Doctor of Pharmacy, UnitedHealth Group, Health, Growth, Red Oak, Oklahoma, Red oak, Pharmaceutical industry, Pharmacy

AHMEDABAD, India, Oct. 16, 2023 /PRNewswire/ -- Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as 'Zydus') a discovery-driven, global lifesciences company announced the appointment of Mr. Punit Patel as President and Chief Executive Officer, Americas.

Key Points: 
  • AHMEDABAD, India, Oct. 16, 2023 /PRNewswire/ -- Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as 'Zydus') a discovery-driven, global lifesciences company announced the appointment of Mr. Punit Patel as President and Chief Executive Officer, Americas.
  • He will be responsible for the business operations of all Zydus entities in North America which include generics, injectables and specialty business, rare and orphan disease portfolio and also future forays into novel therapeutics.
  • Prior to his joining Zydus, Mr. Punit Patel was the President of Red Oak Sourcing, helming a multi-billion-dollar generic portfolio.
  • "We look forward to Punit joining our organisation," said Dr. Sharvil Patel, Managing Director, Zydus Lifesciences Ltd., "As a seasoned and successful business leader, Punit brings rich and varied experience in healthcare and pharmaceuticals to lead Zydus into the future.